Evidence map›Paper›PMID 29371908›Full record

ArticleHereditary cancer in clinical practice2018

Genetic variants of prospectively demonstrated phenocopies in

Mev Dominguez-Valentin, D Gareth R Evans, Sigve Nakken, Hélène Tubeuf, Daniel Vodak, Per Olaf Ekstrøm, Anke M Nissen, Monika Morak, Elke Holinski-Feder, Alexandra Martins and 2 more

Abstract read
In one paragraph

Article in Hereditary cancer in clinical practice, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Look Alike, Sound Alike: Phenocopies in Steroid-Resistant Nephrotic Syndrome.International journal of environmental research and public health · 2020
    Review
  3. Article
  4. Article
  5. Article
  6. TheGenes · 2019
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mev Dominguez-Valentin1Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.ORCID 0000-0001-7856-0057
D Gareth R Evans2Department of Genetic Medicine, The University of Manchester, Manchester Academic Health Science Centre, St. Mary's Hospital, Manchester, UK.
Sigve Nakken1Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Hélène Tubeuf4Inserm-U1245, UNIROUEN, Normandie Univ, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.
Daniel Vodak1Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Per Olaf Ekstrøm1Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Anke M Nissen6Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Ziemssenstr. 1, Munich, Germany.
Monika Morak6Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Ziemssenstr. 1, Munich, Germany.
Elke Holinski-Feder6Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Ziemssenstr. 1, Munich, Germany.
Alexandra Martins4Inserm-U1245, UNIROUEN, Normandie Univ, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.
Pål Møller1Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Eivind Hovig1Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.

Funding

Department of Health RP-PG-0707-10031Department of Health RP-PG-1214-20016
6 · The paper itself

Abstract

backgroundIn kindreds carrying

methodsWomen with BC or gynecological cancer who had tested negative for

resultsWe identified 48 women who were tested negative for their family's

conclusionAll women in breast or breast/ovarian cancer kindreds would benefit from being offered genetic testing irrespective of which causative genetic variants have been demonstrated in their relatives.

Indexed as

BRCA1BRCA2Breast cancerGene panel testingRNA splicing

Identifiers

PMID29371908
PMCPMC5769521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.